Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Family with sequence similarity 71, member C pseudogene" (ENSG00000253391) is a genomic segment classified as a processed pseudogene, resembling the FAM71C gene, but mutated so it cannot encode a functional protein[5][1]. Pseudogenes typically arise through duplication, retrotransposition, or mutation of protein-coding genes. Recent research shows that some pseudogenes can be transcribed to RNA and may influence gene regulation through molecular decoy mechanisms or RNA interference pathways, but most remain nonfunctional "genomic fossils" with no direct cellular or clinical impact[3][5]. There is currently no evidence of regulatory function, disease involvement, or drug interaction for this particular pseudogene. If you seek a therapeutic target, this gene is not appropriate. For information on functional targets, consider searching for the protein-coding version or related active genes.
None. No known drug mechanism for pseudogenes as direct targets[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 71, member C pseudogene (None in standard scientific usage; the gene symbol (FAM71C) is typical for functional counterparts, but this is a pseudogene version.).